Dublin, May 19, 2017 -- Research and Markets has announced the addition of the "Needle-Free Drug Injection Systems - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Needle-Free Drug Injection Systems in US$ Million.
The report profiles 62 companies including many key and niche players such as
- AKRA Dermojet (France)
- Crossject SA (France)
- D'Antonio Consultants International, Inc. (USA)
- Medical International Technologies, Inc. (Canada)
- National Medical Products, Inc. (USA)
- PharmaJet (USA)
- Zogenix, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Needle-Free Drug Injection Systems: An Overview
- Needle-Free Drug Delivery Systems: An Overview
- Brief Glance of Needle-Free Drug Delivery Systems
- Advantages
- Disadvantages
- Needle-Free Drug Injection System: Market Dynamics
- Drivers and Barriers of Needle-free Drug Injection Systems Market
- Increasing Geriatric Population to Drive Market
- Improving Healthcare Expenditure to Foster Growth
- Increasing Incidence of Cancer Bodes Well for Needle-free Drug Injection Systems
- Global Cancer Prevalence Statistics
- Opportunity Indicators
- Expanding Therapeutic Applications to Generate Growth Opportunities
- Competitive Scenario
- Needle-free Jet Injections: Future Burning Bright
- Growth Factors
- Next Generation Needle-free Jet Technologies
- Advantageous to Different Stakeholders
- Applications
- Formulation Challenges
- Current Development Status
- The Road Ahead
- Innovations in Needle-Free Drug Injection System Technology
- Needle-free Arterial Non-Injectable Connector
- The Technology
- Limitations of Evidence
- Pulsed Micro Jets
2. FUTURE APPLICATIONS
- Inactivated Polio Vaccine
- Influenza Vaccine
- Measles-Mumps-Rubella Vaccine
- BCG Vaccine
- Yellow Fever Vaccine
- E. DTP-Hib-hep B Vaccine
- Rabies Vaccine
- Insulin Therapy
- Others
3. DRUG DELIVERY SYSTEMS - AN OVERVIEW
- Oral Vaccines
- Nasal Sprays, Suppositories and Eye and Nose Drops
- Inhalers
- Select Vaccine Inhalers in Development Stage (2016)
- Transdermal
- Injected Fine Mist or Powder
- Jet Injectors
- Iontophoretic Transdermal
- Patches
- Microneedles
- Implants
4. PRODUCT OVERVIEW
- Introduction
- Historical Background
- Mechanism
- Structure of Skin
- Epidermis
- Dermis
- Hypodermis
- Classification of Needle-Free Drug Injection Systems
- Based on Working
- Based on Load Type
- Based on Delivery Site
- Mode of Action of Needle-Free Drug Injection Systems
- Based on Mechanism
- Spring
- Laser
- Energy Propelled System
- Lorentz force
- Device Mechanism
- Gas Propelled/Air Forced
- Future Technologies
- Shock Waves
- Device Mechanism
- Based on Load Type
- Liquid
- Device Mechanism
- Powder
- Device Mechanism
- Projectile/Depot
- Based on Delivery Site
- Intradermal Injector
- Subcutaneous Injector
- Intramuscular Injector
- Material Used for Production
- Designing of Needle-free Injection Systems
- The Production Process
- Manufacturing the Pieces
- Assembling and Labeling
- Packaging
- Quality Control
- Safe Medical Devices
- Auto-Injectors and Pen Injector
- Benefits for Humans
- Greater Patient Acceptance and Compliance
- Enhanced Safety
- Improved Effectiveness
- Swift Injection Time
- Advantages of Using Needle-Free Injectors in Animals
- Disease Transmission Reduction
- Immunology Improvement
- Improvement in Beef Quality
- Employee Safety
- Needle-free Delivery of Liquids and Solids
- Select Needle-Free Drug Injection Systems Present in Market
5. RECENT INDUSTRY ACTIVITY
- PharmaJet® Adds Trivalent and Quadrivalent Influenza Vaccine to Injector System
- Eternity Healthcare's Lenis® Device Bags CE Certification
- PharmaJet® Inks Deal With Serum Institute to Launch Needle- free MMR Vaccine
- Inovio Pharmaceuticals Acquires BioJect Medical Technologies
- PharmaJet® Partners With Vaccibody for HPV Vaccine Development
- Zika Virus DNA Vaccine Clinical Trial Being Conducted With PharmaJet Needle-free Device
- PharmaJet Inks Partnership Agreement with Distributors for Marketing PharmaJet® Across the US
- Antares Pharma Bags FDA Approval for ZOMACTON and ZOMAJet
- Portal Instruments Raises US$25 million in Series B Financing
- West Pharmaceutical Services Bags 510(k) Clearance for Needle-stick Guards
- Crossject Develops Needle-Free Injection System
- The ZENEO Device
- FDA Grants Approval for Stratis Needle-Free Injection System
- Portal Instruments® Raises US$11 million from Sanofi
6. FOCUS ON SELECT PLAYERS
7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 62 (including Divisions/Subsidiaries 67)
- The United States (33)
- Canada (5)
- Japan (2)
- Europe (13)
- - France (3)
- - Germany (2)
- - The United Kingdom (4)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (14)
For more information about this report visit http://www.researchandmarkets.com/research/l2mkpl/needlefree_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery, Infusions and Injectables , Needles and Syringes


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



